CoVs (order Nidovirales, family Coronaviridae, subfamily Coronavirinae) are a group of
highly diverse, single-stranded, enveloped, positivesense, RNA viruses that may cause …

Observational data suggest that the treatment of influenza infection with neuraminidase
inhibitors decreases progression to more severe illness, especially when treatment is started …

Although high mortality has been reported in many COVID-19 studies, very limited
postmortem information from complete autopsies is available. We report the findings in the …

Plasma therapy consists in bringing to a patient in need–in general suffering a severe,
resistant to current therapy, and even lethal infection–plasma or specific, fractioned …

A severe inflammatory immune response with hypercytokinemia occurs in patients
hospitalized with severe influenza, such as avian influenza A (H5N1), A (H7N9), and …

The emergence and spread of antimicrobial-resistant bacterial, viral, and fungal pathogens
for which diminishing treatment options are available is of major global concern. New viral …

Severe influenza A virus infection causes high mortality and morbidity worldwide due to
delayed antiviral treatment and inducing overwhelming immune responses, which contribute …

Introduction− Macrolides can ameliorate inflammation in respiratory diseases, providing
clinical benefits. Data in influenza is lacking. Method− A randomized, open-label, multicenter …

We aimed to study factors influencing outcomes of adults hospitalised for seasonal and
pandemic influenza. Individual-patient data from three Asian cohorts (Hong Kong …

Background Because treatment options for coronavirus disease 2019 (COVID-19) are very
limited, the use of convalescent plasma has bee explored. Case presentation and treatment …